Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6ATAC2P is a pseudogene that resembles the gene for U6atac small nuclear RNA, a component of the minor spliceosome involved in pre-mRNA splicing[4]. Unlike the functional gene, this pseudogene does not encode an active RNA product and is not involved in cellular processes or disease. It is a genomic remnant arising from retrotransposition or gene duplication events and is typically nonfunctional, though such sequences can mark retrotranspositional activity in the genome[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 2, pseudogene (RNU6ATAC2P).